Roche’s Susvimo, for `wet’ age-related macular degeneration (nAMD) approved
The implant is surgically inserted into the eye during a one-time, outpatient procedure and refilled every six months
The implant is surgically inserted into the eye during a one-time, outpatient procedure and refilled every six months
It’s the company’s fourth manufacturing site worldwide. Others are located in the US, UK and China
Researchers at the Feinstein Institutes administer extra vaccine doses as part of the NIH funded study
Subscribe To Our Newsletter & Stay Updated